Topical mitomycin–C is used in :
Mitomycin-C is an antineoplastic antibiotic. Topically, it's used in ophthalmology, right? Like for pterygium or glaucoma surgeries to prevent scarring. Wait, also in dermatology for certain cancers or precancers. But the most classic use is in ophthalmic procedures. Let me think about the options. The user didn't include the options, but the correct answer is supposed to be one of them.
So, the core concept here is the application of mitomycin-C. It's a chemotherapeutic agent that works by cross-linking DNA, inhibiting cell replication. Topically, it's used to prevent fibrosis and scarring in surgeries. The main areas would be ophthalmic surgeries like trabeculectomy for glaucoma, or pterygium excision.
The correct answer would likely be an option related to ophthalmic use. The other options might include other areas like dermatology, oncology, or urology. Let me check. If the options were, say, A: Glaucoma surgery, B: Psoriasis, C: Lung cancer, D: Prostate cancer, then A would be correct.
Wait, but the user's correct answer is missing, so I need to make sure. Since the user is asking for the explanation, I should focus on the correct answer being related to ophthalmic use. The other options would be incorrect because they either refer to systemic uses or other conditions where mitomycin isn't indicated.
Clinical pearl: Remember that mitomycin-C is used topically in ophthalmology to prevent scarring post-surgery. High-yield fact for exams.
So putting it all together, the correct answer would be the option stating its use in glaucoma surgery or pterygium excision. The explanation should clarify the mechanism and why other options are wrong. Make sure to mention the DNA cross-linking effect and the specific surgical applications.
**Core Concept**
Topical mitomycin-C is an antineoplastic agent used to inhibit fibroblast proliferation and prevent scarring in surgical procedures. It functions as a **DNA cross-linking agent**, interfering with DNA replication and cell division.
**Why the Correct Answer is Right**
Topical mitomycin-C is primarily used in **ophthalmic surgeries** (e.g., trabeculectomy for glaucoma or pterygium excision) to prevent postoperative fibrosis and scarring. It suppresses excessive wound healing by targeting fibroblasts and myofibroblasts, reducing the risk of surgical failure due to tissue contraction. Its localized application minimizes systemic toxicity while achieving therapeutic concentrations at the surgical site.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it refers to dermatologic conditions like psoriasis—mitomycin-C is not indicated for non-neoplastic dermatoses.
**Option B:** Incorrect if it refers to systemic cancers—mitomycin-C is used topically for localized fibrotic conditions, not as a systemic chemotherapeutic agent.
**Option C:** Incorrect if it refers to urological applications